Professional Documents
Culture Documents
5 Best Stocks 8th Sept 2011
5 Best Stocks 8th Sept 2011
uk
Alkane energy produce electricity from coal gas. The company operates 12 mid-sized power plants across the UK and sells its output through an electricity distribution network. The groups energy portfolio includes coal mine methane, biogas, conventional gas and coal bed methane. Alkane took a gamble last year and decided to increase its generating capacity in the UK by 26% - adding three new sites to its existing generators. This investment is clearly paying off as theyve been able to meet the ever growing demand for its electricity. The company has made a cracking start to the y e a r. F i r s t q u a r t e r revenues rocketed up over 50% as electricity output increased by 54%. The energy market is volatile so Alkane has been taking advantage of high energy prices by locking-in future revenues. Theyve now got 88% of 2011 production forward contracted
and also have 15% of 2012 projected output locked in. Alkane looks fundamentally cheap. The shares currently trade at an eye-catching forward PE of 7.6 which is even more attractive when compared to a forecasted earnings growth rate of 58%. The price chart shows that the shares have pulled back 30% since May, giving an attractive entry point. 5 year price chart:
Galvan Research and Trading, CMA House, Newham Road, Truro, Cornwall, TR1 2SU Risk Warning Notice: Galvan Research And Trading Ltd is authorised and regulated by the Financial Services Authority (FSA). Whilst every attempt is made to ensure the accuracy of the information provided, no responsibility can be accepted for any inaccuracy. The information provided cannot be relied upon as constituting a recommendation, nor construed as any offer to sell, or any solicitation of any offer to buy investments. No liability is accepted for any loss whether direct or indirect, incidental or consequential, arising out of any of the information being untrue and / or inaccurate, except to the extent caused by the wilful default or gross negligence of Galvan Research And Trading, its employees, or which arises under the Financial Services And Markets Act 2000.
T: +44 (0) 1872 262622 F: +44 (0) 1872 265326 E: mail@galvan.co.uk W: www.galvan.co.uk
Galvan Research and Trading, CMA House, Newham Road, Truro, Cornwall, TR1 2SU Risk Warning Notice: Galvan Research And Trading Ltd is authorised and regulated by the Financial Services Authority (FSA). Whilst every attempt is made to ensure the accuracy of the information provided, no responsibility can be accepted for any inaccuracy. The information provided cannot be relied upon as constituting a recommendation, nor construed as any offer to sell, or any solicitation of any offer to buy investments. No liability is accepted for any loss whether direct or indirect, incidental or consequential, arising out of any of the information being untrue and / or inaccurate, except to the extent caused by the wilful default or gross negligence of Galvan Research And Trading, its employees, or which arises under the Financial Services And Markets Act 2000.
T: +44 (0) 1872 262622 F: +44 (0) 1872 265326 E: mail@galvan.co.uk W: www.galvan.co.uk
Galvan Research and Trading, CMA House, Newham Road, Truro, Cornwall, TR1 2SU Risk Warning Notice: Galvan Research And Trading Ltd is authorised and regulated by the Financial Services Authority (FSA). Whilst every attempt is made to ensure the accuracy of the information provided, no responsibility can be accepted for any inaccuracy. The information provided cannot be relied upon as constituting a recommendation, nor construed as any offer to sell, or any solicitation of any offer to buy investments. No liability is accepted for any loss whether direct or indirect, incidental or consequential, arising out of any of the information being untrue and / or inaccurate, except to the extent caused by the wilful default or gross negligence of Galvan Research And Trading, its employees, or which arises under the Financial Services And Markets Act 2000.
T: +44 (0) 1872 262622 F: +44 (0) 1872 265326 E: mail@galvan.co.uk W: www.galvan.co.uk
Tristel (TSTL)
The serious threat of superbugs such as MRSA is stronger than ever. And whilst the government is desperate to make spending cutbacks, they cannot afford to take ignore this issue. Tristel provide an essential role in the fight against these silent killers. They supply advanced infection control products for use in NHS, private and community hospitals. The company also make products for contamination control in the food and pharmaceutical industries. In other words they keep things clean and free of harmful bacteria. Tristel have a brand new growth strategy in which they are looking to focus on the Primary Care Trust and animal healthcare market. They are also keen to expand the export side of their business opening new offices in Germany and China. The Chinese market in particular, offers a massive growth opportunity. Tristel's Wipes System for the decontamination of delicate medical instruments is going through the registration process with the Chinese authorities to enable it to be marketed. Full approval of this product is expected by the end of the year. Tristels enjoyed five years of uninterrupted revenue growth. And although it has recently faced market pressure like everyone else, revenue growth is forecast to continue. The market has clearly failed to recognise the progress Tristel has made over the past five years, with the shares near the bottom of its five year range. 5 year price chart:
Galvan Research and Trading, CMA House, Newham Road, Truro, Cornwall, TR1 2SU Risk Warning Notice: Galvan Research And Trading Ltd is authorised and regulated by the Financial Services Authority (FSA). Whilst every attempt is made to ensure the accuracy of the information provided, no responsibility can be accepted for any inaccuracy. The information provided cannot be relied upon as constituting a recommendation, nor construed as any offer to sell, or any solicitation of any offer to buy investments. No liability is accepted for any loss whether direct or indirect, incidental or consequential, arising out of any of the information being untrue and / or inaccurate, except to the extent caused by the wilful default or gross negligence of Galvan Research And Trading, its employees, or which arises under the Financial Services And Markets Act 2000.
T: +44 (0) 1872 262622 F: +44 (0) 1872 265326 E: mail@galvan.co.uk W: www.galvan.co.uk
Galvan Research and Trading, CMA House, Newham Road, Truro, Cornwall, TR1 2SU Risk Warning Notice: Galvan Research And Trading Ltd is authorised and regulated by the Financial Services Authority (FSA). Whilst every attempt is made to ensure the accuracy of the information provided, no responsibility can be accepted for any inaccuracy. The information provided cannot be relied upon as constituting a recommendation, nor construed as any offer to sell, or any solicitation of any offer to buy investments. No liability is accepted for any loss whether direct or indirect, incidental or consequential, arising out of any of the information being untrue and / or inaccurate, except to the extent caused by the wilful default or gross negligence of Galvan Research And Trading, its employees, or which arises under the Financial Services And Markets Act 2000.